Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient

AstraZeneca384 enrolled

Overview

Measurement of disease control, treatment adherence and patient knowledge of his/her medication in patients that are receiving a pharmaceutical intervention compared with those patients who receive regular pharmaceutical care.

Study Type

OBSERVATIONAL

Enrollment

384

Conditions

Asthma

Interventions

1OTHER

In the pilot study the objective is to compare 2 different pharmaceutical interventions (A and B) and to assess which one improves disease control, patient adherence and patient knowledge of the medication.

2OTHER

The best intervention used in the pilot study will be chosen and included in the main study.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients who have given their informed consent and expressed interest in participating in the study * Asthmatic Patients Exclusion Criteria: * Patients with communication difficulties. * Persons who obtain symbicort but not for their own use. * Patients with other major diseases: Heart problems, COPD, EMPHYSEMA, lung cancer, AIDS. * Patients with a respiratory infection. * Patients with seasonal asthma. * Pregnant women * Patients who have previously participated in a health education study in asthma.

Locations (2)

Research Site

Madrid, Spain

Malaga

Málaga, Spain

Outcomes

Primary Outcomes

Evaluate the effect of the pharmaceutical intervention on the disease control, treatment adherence and patient knowledge of his/her medication using the MEF, treatment adherence and patient knowledge of the medication indicators.

Time frame: First a Pilot in 3 months and then the final study in 6 months

Secondary Outcomes

Compare disease control in patients who know their medication and those who doesn't.

Time frame: First a Pilot in 3 months and then the final study in 6 months

Compare disease control in patients who comply with their medication with those who doesn't.

Time frame: First a Pilot in 3 months and then the final study in 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.